Dachaigh › Lymphoma follicular › North Carolina › Durham
Sgrùdaidhean clionaigeach Lymphoma follicular ann an Durham, NC
Tha 15 sgrùdaidhean airson Lymphoma follicular a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
A’ fastadhÌre 2/3
- Duke Cancer Center Clinic 1B/C Onc/Heme ( Site 1307), Durham
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
A’ fastadhÌre 3
- University of North Carolina, Chapel Hill · 10 mìle air falbh
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
A’ fastadhÌre 3
- Duke Cancer Institute, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mìle air falbh
Pain With Dementia
A’ fastadhFàilte do shaor-thoilich fhallain
- Duke University Medical Center, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
A’ fastadh
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 mìle air falbh
Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
A’ fastadhÌre 1
- Duke Univerisity, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
A’ fastadhÌre 1
- Duke University, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
A’ fastadhÌre 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mìle air falbh
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
A’ fastadhÌre 1
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mìle air falbh
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
A’ fastadhSgrùdadh amharc
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
A’ fastadhÌre 1
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Sgrùdaidhean Lymphoma follicular ann am bailtean eile
- New York City, NY24 sgrùdaidhean
- Milwaukee, WI19 sgrùdaidhean
- Nashville, TN18 sgrùdaidhean
- Houston, TX18 sgrùdaidhean
- Boston, MA17 sgrùdaidhean
- Baldwin Park, CA16 sgrùdaidhean
- Seattle, WA15 sgrùdaidhean
- Salt Lake City, UT13 sgrùdaidhean
- Columbus, OH13 sgrùdaidhean
- Chicago, IL12 sgrùdaidhean
- San Antonio, TX12 sgrùdaidhean
- Philadelphia, PA12 sgrùdaidhean
Sgrùdaidhean eile ann an Durham
- Aillse a' bhroilleach64 sgrùdaidhean
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag39 sgrùdaidhean
- Myeloma iomaill37 sgrùdaidhean
- Leukemia myeloid geur33 sgrùdaidhean
- Ailse metastatach33 sgrùdaidhean
- Aillse Prostata32 sgrùdaidhean
- Ailseachadh nan Sgamhan32 sgrùdaidhean
- Aillse colorectal28 sgrùdaidhean
- Cancer Ovarian27 sgrùdaidhean
- Leukemia Lymphocytic Cronach27 sgrùdaidhean
- Fàilligeadh a' Chridhe26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.